List price per month: $1,349.02* Zepbound (tirzepatide) Form: Injectable GLP-1 + GIP receptor agonist Uses: FDA-approved for weight loss in adults with obesity or overweight plus a weight-related health condition and to treat moderate to severe obstructive sleep apnea in adults with obesity
After incubation at 37C for 25 minutes, the oocytes were washed and examined under a Zeiss LSM 880 confocal microscope
Some effects of overdosing are as follows: Severe drowsiness Respiratory depression Confusion Impaired coordination Diminished reflexes Coma Death If there is suspicion of a Xanax overdose, seek immediate medical attention
References Lee, C., Zeng, J., Drew, B.G., Sallam, T., Martin-Montalvo, A., Wan, J., Kim, S.J., Mehta, H., Hevener, A.L., de Cabo, R., & Cohen, P